APLS: Apellis Pharmaceuticals Inc Company Profile & Statistics

About

Apellis Pharmaceuticals, Inc. is a clinical-stage biotech focused on the development of novel therapeutics, which work through the inhibition of the complement system, specially targeting the C3 protein of the complement system to treat autoimmune and inflammatory diseases.

Info & Links

CEO

Cedric Francois

Headquarters

100 FIFTH AVENUE
WALTHAM, MA 02451, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

706

Apellis Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization²

4.13B

Enterprise Value

4.19B

Enterprise Value/EBITDA(ttm)

-20.41

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

5.76

Price to Book(mrq)

17.39

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

86.51%

Operating Margin(ttm)

-34.70%

Profit Margin(ttm)

-36.78%

Return on Equity(ttm)

-103.11%

Return on Invested Capital(ttm)

-62.82%

Return on Assets(ttm)

-28.96%

Income Statement

Revenue(ttm)

715.22M

Revenue Per Share(ttm)

5.75

Gross Profit(ttm)

618.44M

EBITDA(ttm)³

-205.10M

Net Income Available to Common(ttm)

-250.10M

Diluted EPS(ttm)

-2.03

Share Statistics

Beta (5Y Monthly)

0.94

52-Week Change

-47.99%

S&P 500 52-Week Change

24.21%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

124.39M

Dividend Yield

0.00%

Float⁴

115.93M

% Held by Insiders

6.80%

% Held by Institutions

96.29%

Balance Sheet

Total Cash(mrq)

398.24M

Total Cash Per Share(mrq)

3.20

Total Debt(mrq)

452.25M

Total Debt/Equity(mrq)

190.72%

Current Ratio(mrq)

4.36%

Quick Ratio(mrq)

3.73%

Book Value Per Share(mrq)

1.94

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.86

Free Cash Flow(ytd)

-107.61M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

APLS

Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals Inc Profile